Neuromed Technologies, Inc.
Records under this name other than patents Neuromed Technologies, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Neuromed Technologies, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,294,533 | Calcium channel blockers Formerly held Term ended Term ended Sep 23, 2019 · From the USPTO record | Term ended | Term ended Sep 23, 2019 | From the USPTO record |
| US 6,011,035 | Calcium channel blockers Formerly held Term ended Term ended Jun 29, 2018 · From the USPTO record | Term ended | Term ended Jun 29, 2018 | From the USPTO record |
| US 6,387,897 | Preferentially substituted calcium channel blockers Formerly held Term ended Ended no later than Jun 29, 2018 · From the USPTO record | Term ended | Ended no later than Jun 29, 2018 | From the USPTO record |
| US 7,649,092 | Urea derivatives as calcium channel blockers Formerly held Lapsed on the fee record Ended Jan 19, 2018 · From the USPTO record | Lapsed on the fee record | Ended Jan 19, 2018 | From the USPTO record |
| US 6,951,862 | Calcium channel blockers comprising two benzhydril moieties Formerly held Lapsed on the fee record Ended Oct 4, 2017 · From the USPTO record | Lapsed on the fee record | Ended Oct 4, 2017 | From the USPTO record |
| US 7,378,420 | Urea derivatives as calcium channel blockers Formerly held Lapsed on the fee record Ended May 27, 2016 · From the USPTO record | Lapsed on the fee record | Ended May 27, 2016 | From the USPTO record |
| US 7,294,485 | Rat calcium channel subunits and related probes, cell lines and methods Formerly held Lapsed on the fee record Ended Nov 13, 2015 · From the USPTO record | Lapsed on the fee record | Ended Nov 13, 2015 | From the USPTO record |
| US 7,270,949 | Fluorescence based T-type channel assay Formerly held Lapsed on the fee record Ended Sep 18, 2015 · From the USPTO record | Lapsed on the fee record | Ended Sep 18, 2015 | From the USPTO record |
| US 6,617,322 | Preferentially Substituted Calcium Channel Blockers Formerly held Lapsed on the fee record Ended Sep 9, 2015 · Low confidence | Lapsed on the fee record | Ended Sep 9, 2015 | Low confidence |
| US 7,244,758 | N-type calcium channel blockers Formerly held Lapsed on the fee record Ended Jul 17, 2015 · From the USPTO record | Lapsed on the fee record | Ended Jul 17, 2015 | From the USPTO record |